MyAverix Finance
NS · Pharmaceuticals
Venus Remedies Ltd (VENUSREM)
Pharmaceuticals & Biotechnology
Venus Remedies Ltd (VENUSREM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $23.71B, P/E ratio is 23.88, net margin is 8.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VENUSREM
Venus Remedies Ltd (VENUSREM) — FAQ
What is Venus Remedies Ltd's market cap?
Venus Remedies Ltd (VENUSREM) has a reported market cap of $23.71B (data as of 2026-07-11).
What is VENUSREM's P/E ratio?
The price-to-earnings (P/E) ratio for Venus Remedies Ltd (VENUSREM) is 23.88 (data as of 2026-07-11).
Does Venus Remedies Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Venus Remedies Ltd (VENUSREM). Check the MyAverix Finance app for the latest dividend data.
What sector is Venus Remedies Ltd in?
Venus Remedies Ltd (VENUSREM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is VENUSREM listed on?
VENUSREM is listed on NS.
What is Venus Remedies Ltd's net margin?
Venus Remedies Ltd (VENUSREM) reports a net margin of 8.6% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.